ArticleOncology letters2026
Evaluating computer-assisted mandibular reconstruction: Outsourced vs. in-house approaches.
Article in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- B-onic Platform: A Single-Center Clinical Evaluation of an Integrated FabLab Workflow for Patient-Specific Surgical Planning and XR-Based Validation.Journal of clinical medicine · 2026Article
- B-Onic Platform for Point-of-Care 3D Printing in Oral and Maxillofacial Surgery: Clinical Implementation and Surgical Impact.Medicina (Kaunas, Lithuania) · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mandibular reconstruction following segmental resection, often necessitated by oral malignancies, is a complex procedure that markedly affects postoperative function and aesthetics. Computer-assisted surgery (CAS) has emerged as a valuable tool for enhancing surgical precision in oncological head and neck reconstruction. The present study evaluated the accuracy of mandibular reconstruction using three approaches: Conventional (non-CAS), outsourced CAS (TruMatch) and an in-house CAS system developed at The University of Osaka Graduate School of Dentistry (Suita, Japan). A total of 32 cases, predominantly involving malignant tumors, were retrospectively analyzed using three-dimensional model overlay techniques to compare pre- and postoperative outcomes. While both CAS methods significantly improved accuracy compared with the non-CAS approach, no statistical difference was found between the outsourced and in-house CAS groups. These findings suggested that in-house CAS systems can achieve comparable precision to commercial solutions, offering a cost-effective and accessible alternative for advanced mandibular reconstruction in oncology settings. The results support broader adoption of in-house CAS approaches, particularly in time-sensitive or resource-limited cancer surgeries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.